NCT05509400 Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use Status COMPLETED Phase PHASE4
NCT05492695 Tandem OnabotulinumtoxinA Galcanezumab Emerging Therapeutic Headache Elimination Research Study Status TERMINATED Phase PHASE4
NCT05477095 A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05468801 Efficacy of Individualized Homeopathic Remedies on Migraine: a Randomized, Triple-blind, Placebo Controlled Study. Status UNKNOWN Phase NA
NCT05458011 A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine Status COMPLETED Phase PHASE3
NCT05452239 A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache Status COMPLETED Phase PHASE4
NCT05442008 Predictive Role of MIDAS Reduction at 3 Months for Erenumab Treatment Status COMPLETED Phase N/A
NCT05427630 Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment Status SUSPENDED Phase PHASE2
NCT05415020 Determining the Utility of a Behavioral Intervention in Chronic Migraine Status RECRUITING Phase NA
NCT05411978 Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients Status UNKNOWN Phase PHASE4
NCT05399485 Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only) Status COMPLETED Phase PHASE3
NCT05399459 Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only) Status COMPLETED Phase PHASE3
NCT05382832 Botox Vs Spinal Cord Stimulation in the Treatment of Refractory Migraine Clinical Trial Status UNKNOWN Phase NA
NCT05375097 Real-world Impact of Erenumab on Sick-leaves, Health Care Resource Use and Comorbidities. Status COMPLETED Phase N/A